{"editorial":{"content_id":"648934fd-3e27-4334-b95f-9aafbfeb3913","slug":"anvisaunder-labz","content_type":"news","title":"Anvisa撤销Under Labz补充剂注册，在巴保健品中资需重审合规链","summary":"巴西Anvisa取消Under Labz品牌Dimethylex Fluid Caps补充剂注册并实施自愿召回，产品已禁售。对在巴从事保健品、膳食补充剂进口或分销的中资企业而言，这是一次监管收紧信号，需核查自身产品注册状态与供应链合规。","body":"巴西国家卫生监督局（Anvisa）通报，Under Labz品牌的补充剂产品Dimethylex Fluid Caps已被取消注册，并实施自愿召回。该产品的常规化状态（即注册许可）已被撤销，意味着其不再被允许在巴西市场上销售。此次召回为自愿性质，由企业主动发起，但具体原因未在原文中说明。对于在巴西从事保健品、膳食补充剂及营养品进口和分销的中资企业而言，这一事件提示Anvisa对补充剂类产品的注册后监管正在趋严，相关企业的合规审查频率和供应链溯源要求可能随之提升。\n\n巴西国家卫生监督局（Anvisa）宣布，Under Labz品牌的补充剂产品Dimethylex Fluid Caps的注册已被取消，并因此实施自愿召回。该产品的常规化状态被撤销，意味着其不再被允许在巴西市场销售。召回为自愿性质，由企业主动发起，但具体原因未在原文中说明。底稿未披露事件发生时间、涉及批次数量或具体违规细节，也未提及该产品是否曾在巴西市场广泛流通。\n\n底稿未涉及中资企业直接影响，但通过监管传导机制，这一事件对在巴从事保健品、膳食补充剂、运动营养品类进口或分销的中资企业具有间接警示意义。Anvisa对补充剂类产品的注册审批和上市后监管趋严，意味着中资企业若涉及同类产品的注册持有、代工生产或跨境分销，需重新核查自身产品的注册状态、成分合规性及与Anvisa的沟通记录。对采购环节而言，若中资企业曾将Under Labz或类似品牌作为供应商或贴牌合作方，需立即排查库存和已签订单。对合规环节而言，此次撤销注册并召回表明Anvisa对补充剂产品的成分安全、标签声明或生产工艺存在更高审查标准，中资企业的法务和合规团队应关注Anvisa后续是否发布针对同类成分或剂型的补充规定。\n\n底稿显示，Anvisa取消了该产品的注册并实施自愿召回，但未说明具体原因。CBI认为，Anvisa对补充剂类产品的监管逻辑正在从\"注册后宽松\"转向\"全生命周期追踪\"，此次撤销注册并召回可能涉及产品成分安全性、标签合规性或生产工艺不符合现行法规。CBI观察，巴西保健品市场近年来快速增长，Anvisa对进口补充剂的审查力度同步上升，中资企业若以巴西为南美分销中心，需将Anvisa的注册维护和定期报告义务纳入常态化合规成本，而非一次性审批动作。\n\n待观察的跟踪点包括：Anvisa是否会在未来30天内发布针对Dimethylex Fluid Caps召回原因的补充说明或技术报告；Under Labz品牌在巴西注册的其他产品是否会被连带审查或撤销；Anvisa是否会在2025年内针对进口补充剂类产品出台更严格的注册后抽检或年度报告要求。中资企业可监控Anvisa官网的决议公告栏及产品注册状态查询系统，以获取上述动态。","why_it_matters":"Anvisa对补充剂注册撤销并召回，直接影响在巴保健品中资企业的合规审查与供应链风险管控。","cbi_observation":"事实层面，Anvisa撤销了Under Labz一款补充剂的注册并实施自愿召回，但未披露具体原因。CBI认为，这一动作释放了Anvisa对补充剂类产品上市后监管趋严的信号，中资企业应将其视为合规成本上升的前兆，而非孤立事件。","direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["合规","企业动态","br-health"],"content_level":"编辑整理","event_type":"监管变化","audience_tags":["在巴中资企业","贸易商","法务团队"],"event_location":"在巴西从事保健品、膳食补充剂进口或分销的中资企业","verification_status":"unverified","published_at":"2026-09-03T11:01:00.978Z","display_date":"2026-09-03","source_published_at":null,"source_url":"https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-informa-recolhimento-voluntario-de-suplemento-da-marca-under-labz","source_name":"Anvisa","source_language":"pt","author_name":"Clara Lin","risk_level":"low","risk_flags":["compliance_risk","regulatory_uncertainty"],"opportunity_flags":[],"trend_signals":["policy_tightening"]},"intelligence":{"intel_id":"60fedddf-3528-4294-a3ab-8e15a5216bc0","version":1,"event_type":"监管表态","event_date":null,"main_entities":[{"name":"巴西国家卫生监督局（Anvisa）","role":"发布撤销注册与召回决定的监管机构","type":"regulator","country":"巴西","normalized_name":null},{"name":"Under Labz","role":"涉事补充剂品牌持有方","type":"company","country":"巴西","normalized_name":null},{"name":"Dimethylex Fluid Caps","role":"被撤销注册并实施自愿召回的补充剂产品","type":"product","country":"巴西","normalized_name":null}],"main_action":"巴西Anvisa取消Under Labz品牌补充剂注册并实施自愿召回，产品禁售。","key_numbers":[],"facts":[{"verified":false,"statement":"Anvisa通报取消了Under Labz品牌产品Dimethylex Fluid Caps的注册。","source_excerpt":null},{"verified":false,"statement":"该产品被实施自愿召回，不再被允许在巴西市场销售。","source_excerpt":null},{"verified":false,"statement":"Anvisa未在底稿中说明具体撤销原因及涉及批次数量。","source_excerpt":null}],"assessments":[{"statement":"Anvisa对补充剂类产品的注册后监管趋严，可能提升中资保健品企业的合规审查频率。","confidence":"medium","basis_fact_index":null},{"statement":"此次行动可能涉及产品成分安全、标签合规性或生产工艺不符合现行法规。","confidence":"medium","basis_fact_index":null}],"actions":[{"target":"user","priority":"high","description":"排查与Under Labz或其类似品牌的库存、订单及供应关系。"},{"target":"user","priority":"high","description":"核查自身在巴西注册的保健品及补充剂产品合规状态与Anvisa沟通记录。"},{"target":"system","priority":"normal","description":"持续监控Anvisa官网决议公告及产品注册状态查询系统。"}],"affected_audience":["在巴西从事保健品、膳食补充剂及营养品进口和分销的中资企业","与Under Labz或类似品牌有代工、贴牌合作的中资企业"],"risk_flags":["compliance_risk","regulatory_uncertainty"],"opportunity_flags":[],"trend_signals":["policy_tightening"],"follow_up_needed":true,"follow_up_questions":["Anvisa是否会在未来30天内发布Dimethylex Fluid Caps召回原因的补充说明或技术报告？","Under Labz在巴西注册的其他产品是否会被连带审查或撤销？","Anvisa是否会在2025年内对进口补充剂出台更严格的注册后抽检或年度报告要求？"],"related_topics":["巴西保健品监管","Anvisa注册撤销","膳食补充剂供应链合规","中资企业巴西市场准入"],"verification_status":"unverified","confidence_score":0.75,"generated_at":"2026-09-03T11:01:12.832Z"},"meta":{"canonical_url":"https://chinabrazilinsight.com/news/anvisaunder-labz","api_url":"https://chinabrazilinsight.com/api/public/content/anvisaunder-labz","markdown_url":"https://chinabrazilinsight.com/api/public/content/anvisaunder-labz?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/anvisaunder-labz?view=json","last_updated":"2026-09-03T11:01:12.891Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}